161 related articles for article (PubMed ID: 1960561)
21. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
[TBL] [Abstract][Full Text] [Related]
22. Purging in BCR-ABL-positive acute lymphoblastic leukemia using immunomagnetic beads: comparison of residual leukemia and purging efficiency in bone marrow vs peripheral blood stem cells by semiquantitative polymerase chain reaction.
Atta J; Fauth F; Keyser M; Petershofen E; Weber C; Lippok G; Hoelzer D; Martin H
Bone Marrow Transplant; 2000 Jan; 25(1):97-104. PubMed ID: 10654022
[TBL] [Abstract][Full Text] [Related]
23. Rapid engraftment after autologous transplantation utilizing marrow and recombinant granulocyte colony-stimulating factor-mobilized peripheral blood stem cells in patients with acute myelogenous leukemia.
Demirer T; Buckner CD; Appelbaum FR; Petersen FB; Rowley S; Weaver CH; Lilleby K; Sanders J; Chauncey T; Storb R
Bone Marrow Transplant; 1995 Jun; 15(6):915-22. PubMed ID: 7581091
[TBL] [Abstract][Full Text] [Related]
24. In vitro marrow purging in chronic myelogenous leukemia: effect of mafosfamide and recombinant granulocyte--macrophage colony-stimulating factor.
Carlo-Stella C; Mangoni L; Piovani G; Almici C; Garau D; Caramatti C; Rizzoli V
Bone Marrow Transplant; 1991 Oct; 8(4):265-73. PubMed ID: 1756324
[TBL] [Abstract][Full Text] [Related]
25. Autologous bone marrow transplantation for childhood acute lymphoblastic leukemia: a novel combined approach consisting of ex vivo marrow purging, modulation of multi-drug resistance, induction of autograft vs leukemia effect, and post-transplant immuno- and chemotherapy (PTIC).
Houtenbos I; Bracho F; Davenport V; Slack R; van de Ven C; Suen Y; Killen R; Shen V; Cairo MS
Bone Marrow Transplant; 2001 Jan; 27(2):145-53. PubMed ID: 11281383
[TBL] [Abstract][Full Text] [Related]
26. Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.
Yeager AM; Kaizer H; Santos GW; Saral R; Colvin OM; Stuart RK; Braine HG; Burke PJ; Ambinder RF; Burns WH
N Engl J Med; 1986 Jul; 315(3):141-7. PubMed ID: 3523241
[TBL] [Abstract][Full Text] [Related]
27. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
Lemoli RM; Gasparetto C; Scheinberg DA; Moore MA; Clarkson BD; Gulati SC
Blood; 1991 Apr; 77(8):1829-36. PubMed ID: 2015406
[TBL] [Abstract][Full Text] [Related]
28. The effect of graft purging with 4-hydroperoxycyclophosphamide in autologous bone marrow transplantation for acute myelogenous leukemia.
Miller CB; Rowlings PA; Zhang MJ; Jones RJ; Piantadosi S; Keating A; Armitage JO; Calderwood S; Harris RE; Klein JP; Lazarus HM; Linker CA; Sobocinski KA; Weisdorf D; Horowitz MM
Exp Hematol; 2001 Nov; 29(11):1336-46. PubMed ID: 11698130
[TBL] [Abstract][Full Text] [Related]
29. Autologous bone marrow transplantation in childhood acute lymphoid leukemia with use of purging.
Billett AL; Sallan SE
Am J Pediatr Hematol Oncol; 1993 May; 15(2):162-8. PubMed ID: 8498641
[TBL] [Abstract][Full Text] [Related]
30. In vitro sensitivity of human hematopoietic progenitor cells to 4-hydroperoxycyclophosphamide.
Ratajczak MZ; Ratajczak J; Kuczynski W; Light B; Lusk EJ; Gewirtz AM
Exp Hematol; 1993 Dec; 21(13):1663-7. PubMed ID: 8243568
[TBL] [Abstract][Full Text] [Related]
31. Synergistic effect of 4-hydroperoxycyclophosphamide and etoposide on a human promyelocytic leukemia cell line (HL-60) demonstrated by computer analysis.
Chang TT; Gulati SC; Chou TC; Vega R; Gandola L; Ibrahim SM; Yopp J; Colvin M; Clarkson BD
Cancer Res; 1985 Jun; 45(6):2434-9. PubMed ID: 3857119
[TBL] [Abstract][Full Text] [Related]
32. Prompt haemopoietic reconstitution following hyperthermia purged autologous marrow and peripheral blood stem cell transplantation in acute myeloid leukaemia.
Herrmann RP; O'Reilly J; Meyer BF; Lazzaro G
Bone Marrow Transplant; 1992 Sep; 10(3):293-5. PubMed ID: 1358379
[TBL] [Abstract][Full Text] [Related]
33. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
[TBL] [Abstract][Full Text] [Related]
34. Chromosome abnormalities in patients treated with 4-hydroperoxycyclophosphamide-purged autologous bone marrow transplantation.
Shah NK; Wingard JR; Piantadosi S; Rowley S; Santos G; Griffin CA
Cancer Genet Cytogenet; 1993 Feb; 65(2):135-40. PubMed ID: 8453599
[TBL] [Abstract][Full Text] [Related]
35. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
37. Treatment of multiple myeloma with intensive chemotherapy followed by autologous BMT using marrow purged with 4-hydroperoxycyclophosphamide.
Reece DE; Barnett MJ; Connors JM; Klingemann HG; O'Reilly SE; Shepherd JD; Sutherland HJ; Phillips GL
Bone Marrow Transplant; 1993 Feb; 11(2):139-46. PubMed ID: 8435663
[TBL] [Abstract][Full Text] [Related]
38. The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia.
Wang C; Qiao Z; Yang L; Ma L; Zhang H; Zhang J
Chin Med J (Engl); 1996 Apr; 109(4):304-7. PubMed ID: 8758293
[TBL] [Abstract][Full Text] [Related]
39. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
Stilz R; Grünebach F; Bader P; Vogel W; Kanz L; Brugger W; Scheding S
J Hematother Stem Cell Res; 2001 Dec; 10(6):777-85. PubMed ID: 11798504
[TBL] [Abstract][Full Text] [Related]
40. Correlation of hematologic recovery with CFU-GM content of autologous bone marrow grafts treated with 4-hydroperoxycyclophosphamide. Culture after cryopreservation.
Rowley SD; Piantadosi S; Santos GW
Bone Marrow Transplant; 1989 Sep; 4(5):553-8. PubMed ID: 2790333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
